Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2019
|
| Online Access: | http://eprints.uanl.mx/15810/1/12.pdf |
| Description not available. |